ISPOR - Is the Orphan Drug Act Being used as a Loophole to Extend Periods of Drug Exclusivity?

Full Text

Is the Orphan Drug Act Being used as a Loophole to Extend Periods of Drug Exclusivity?

Abstract

Authors

WV Padula S Parasrampuria M Socal G Anderson

Back to Volume 21, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now